ODTX
Odyssey Therapeutics, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$825.55M
P/E Ratio
—
EPS
$-5.39
Beta
—
52W High
$20.30
52W Low
$15.35
50-Day MA
$17.38
200-Day MA
$17.38
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Odyssey Therapeutics, Inc. Common Stock
Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company is headquartered in Boston, Massachusetts.
Fundamentals
| Revenue (TTM) | $2.98M |
| Gross Profit (TTM) | $-118.20M |
| EBITDA | $-150.80M |
| Operating Margin | -10740.00% |
| Return on Equity | -85.50% |
| Return on Assets | -41.70% |
| Revenue/Share (TTM) | $0.10 |
| Book Value | $-22.50 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | 277.40 |
| EV/Revenue | 227.87 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $47.17M |
| Float | $11.59M |
| % Insiders | 1.97% |
| % Institutions | 38.41% |
More HEALTHCARE Stocks
Data last updated: 5/25/2026